Literature DB >> 31034898

Prevalence and vascular risk factors of basal ganglia calcifications in patients at risk for cerebrovascular disease.

Esther J M de Brouwer1, Remko Kockelkoren2, Jill B De Vis2, Jan Willem Dankbaar2, Birgitta K Velthuis2, Richard Ap Takx2, Annemarieke De Jonghe3, Marielle H Emmelot-Vonk4, Huiberdina L Koek4, Pim A de Jong2.   

Abstract

BACKGROUND AND
PURPOSE: Risk factors for and meaning of basal ganglia calcifications outside Fahr syndrome are poorly understood. We aimed to assess the prevalence of basal ganglia calcifications and the association with vascular risk factors.
MATERIALS AND METHODS: 1133 patients suspected of acute ischemic stroke from the Dutch acute stroke (DUST) study who underwent thin-slice unenhanced brain CT were analyzed. Basal ganglia calcifications were scored bilaterally as absent, mild (dot), moderate (multiple dots or single artery) and severe (confluent). Uni- and multivariable logistic regression analysis was used to determine possible risk factors (age, gender, history of stroke, smoking, hypertension, diabetes mellitus, hyperlipidemia, body mass index (BMI), renal function and family history of cardiovascular disease under 60 years) for presence of basal ganglia calcifications and ordinal regression analysis for severity of basal ganglia calcifications.
RESULTS: Mean age was 67.4 years (SD: 13.8), 56.8% were male. 337 (29.7%) patients had basal ganglia calcifications, of which 196 (58%) were mild, 103 (31%) moderate, 38 (11%) severe. In multivariable logistic regression analysis, age (OR: 1.02, 95% CI 1.01-1.03, P < 0.01) and BMI (OR: 0.95, 95% CI 0.91-0.98, p 0.01) were significantly associated with the presence of basal ganglia calcifications. Ordinal regression analysis gave comparable results. Age (OR: 1.02, 95% CI 1.01-1.03, P < 0.01) and BMI (OR: 0.95, 95% CI 0.92-0.99, P 0.01) were significantly associated with severity of basal ganglia calcifications.
CONCLUSIONS: In this study with patients suspected of acute ischemic stroke, basal ganglia calcifications were common and significantly associated with older age and lower BMI.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Multidetector-row computed tomography; Risk factors

Mesh:

Year:  2019        PMID: 31034898     DOI: 10.1016/j.neurad.2019.04.002

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  4 in total

1.  Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager-horticulturalists.

Authors:  Margaret Gatz; Wendy J Mack; Helena C Chui; E Meng Law; Giuseppe Barisano; M Linda Sutherland; James D Sutherland; Daniel Eid Rodriguez; Raul Quispe Gutierrez; Juan Copajira Adrian; Jesus Bani Cuata; Amy R Borenstein; Ellen E Walters; Andrei Irimia; Christopher J Rowan; L Samuel Wann; Adel H Allam; Randall C Thompson; Michael I Miyamoto; David E Michalik; Daniel K Cummings; Edmond Seabright; Angela R Garcia; Paul L Hooper; Thomas S Kraft; Caleb E Finch; Gregory S Thomas; Jonathan Stieglitz; Benjamin C Trumble; Michael D Gurven; Hillard Kaplan
Journal:  Alzheimers Dement       Date:  2022-03-09       Impact factor: 16.655

2.  Reconstructing the blood metabolome and genotype using long-range chromatin interactions.

Authors:  Tayaza Fadason; William Schierding; Nikolai Kolbenev; Jiamou Liu; John R Ingram; Justin M O'Sullivan
Journal:  Metabol Open       Date:  2020-03-19

3.  Histology and computed tomography of incidental calcifications in the human basal ganglia.

Authors:  Esther J M de Brouwer; Pim A de Jong; Annemarieke De Jonghe; Marielle H Emmelot-Vonk; Huiberdina L Koek; Jan-Willem Dankbaar; Firdaus A A Mohamed Hoesein; Wim Van Hecke
Journal:  Neuroradiology       Date:  2021-03-20       Impact factor: 2.804

4.  Prevalence of basal ganglia and carotid artery calcifications in patients with permanent hypoparathyroidism after total thyroidectomy.

Authors:  Leyre Lorente-Poch; Sílvia Rifà-Terricabras; Juan José Sancho; Danilo Torselli-Valladares; Sofia González-Ortiz; Antonio Sitges-Serra
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.